Related by context. All words. (Click for frequent words.) 70 Initiates Clinical 67 Initiates Clinical Trial 66 RNAi Therapeutic 65 Successfully Completes Phase 65 targeted radiotherapeutic 64 Bioral Amphotericin B 64 Presents Preclinical Data 64 Protexia R 63 RNAi Therapeutics 63 lucinactant 63 Pafuramidine 63 Receives Orphan Drug Designation 63 Fast Track Status 63 Receives Orphan Drug 63 Awarded Qualifying Therapeutic 63 Initiate Clinical Trial 63 Initiates Phase II 63 Files IND 63 Protexia ® 63 Supernus Pharmaceuticals 62 SBIR Grant 62 Granted Orphan Drug 62 immunotherapeutic vaccine 62 Civacir 62 Small Molecule 62 Fabry Disease 62 Valortim TM 62 novel oral anticoagulant 62 NIH NIAID 62 Cethromycin 62 Reports Preclinical Data 62 HDL Selective Delipidation 61 acetonide FA 61 Begin Clinical Trials 61 Systemic Delivery 61 Hepatitis C Virus HCV 61 Drug Candidate 61 Iluvien TM 61 PEGylated interferon 61 Factor VIIa 61 Completes Patient Enrollment 61 Protexia 61 candidate TNFerade biologic 61 molecular imaging radiopharmaceutical 61 FOLOTYN ® 61 rxRNA 61 Prochymal TM 61 anti botulism antibody 61 Files Investigational 61 trastuzumab DM1 T DM1 61 Phase 2b Clinical Trial 61 Patent Covering 61 Presents Preclinical 61 Personalized Immunotherapy 61 immunodeficiency disorders 61 anti infective treatments 61 Liprotamase 61 Pandemic Influenza Vaccine 61 NEUMUNE 61 Therapeutic Vaccine 61 Immunotherapeutic 61 adenoviral vectors 61 Medical Countermeasures 60 Wellstat 60 Anti Tumor 60 SparVax ™ 60 IL# PE#QQR 60 biodefense countermeasure 60 Meets Primary Endpoint 60 Zelos Therapeutics 60 recombinant subunit vaccine 60 Xcytrin R 60 Demonstrates Ability 60 receptor tyrosine kinase inhibitor 60 Orphan Status 60 Monoclonal Antibody 60 PDE4 inhibitor 60 Potelligent Technology 60 CINTREDEKIN BESUDOTOX 60 RNAi therapeutic targeting 60 Neumune 60 SparVax 60 novel immunotherapies 60 Alferon N 60 Initiates Enrollment 60 Pandemic Influenza Vaccines 60 Neutrolin ® 60 Pimavanserin 60 rPA Anthrax Vaccine 60 Mitigation Strategies 60 Myocet 60 Submits Response 60 Nonclinical 60 ONCONASE R 59 Thiovir 59 Present Preclinical Data 59 Panzem R 59 Initiates Phase III 59 ALN TTR 59 Therapeutic Antibody 59 Immune Therapy 59 Metabolic Disease 59 Macrolide 59 Antibody Drug Conjugate 59 recombinant biopharmaceutical 59 virosome 59 pDNA vaccine 59 Trofex 59 Kosan dependence 59 Squalamine 59 Protectan CBLB# 59 Receive Milestone Payment 59 novel antiviral therapeutics 59 Corixa Corporation 59 radiation countermeasure 59 Receives Milestone Payment 59 SBIR Contract 59 Collaborators Present 59 molecular chaperone regulation 59 Prodarsan R 59 FDA Approvals 59 Chimigen TM 59 Collategene 59 Curaxin 59 biodefense vaccines 59 Kinase Inhibitor 59 BrachySil ™ 59 AFRRI 59 Mipomersen 59 ALN PCS 59 Enhanze 59 ZFP Therapeutics 59 Submits Investigational 59 proprietary PEGylation 59 Restanza 59 OHR/AVR# 59 AVP #D# 59 NTDDS 59 Hematopoietic 59 NPC 1C 59 Epothilone 59 Kinase Inhibitors 59 BLP# Liposome Vaccine 59 Archexin 59 intranasal insulin product 59 Alvine Pharmaceuticals 59 JAK2 Inhibitor 59 Heart Transplant Recipients 59 vaginally administered lidocaine 58 Psoriasis Drug 58 FDA Accepts 58 docetaxel Taxotere ® 58 kidney urologic 58 OvaRex R 58 ATG Fresenius S 58 Nereus Pharmaceuticals 58 NDA Submission 58 Hsp# Inhibitor 58 therapeutic monoclonal antibody 58 KaloBios 58 Preclinical Data 58 Novel Therapeutic 58 Nasdaq SGEN 58 CEQ# 58 CYT# potent vascular disrupting 58 thalidomide Thalomid 58 YONDELIS R 58 oral antiviral 58 Patient Enrollment 58 Phase IIb Clinical Trial 58 Lenocta 58 Licenses Novel 58 Nanotherapeutics 58 Molecular Diagnostic 58 Anticancer Agent 58 Achieves Primary Endpoint 58 TKM Ebola 58 Phase IIb clinical trials 58 protein hydrogel 58 HepaGam B 58 Oral Calcitonin 58 PHX# 58 reslizumab 58 HepDirect prodrug 58 Cellerant 58 JAK2 inhibitor 58 Calcitonin 58 RiVax 58 bortezomib Velcade 58 novel immunomodulatory 58 non nucleoside HCV 58 MGd 58 generation purine nucleoside 58 Receives Approvable Letter 58 KAI Pharmaceuticals 58 IND Filing 58 BrachySil TM 58 Guanilib 58 Intarcia 58 AN# novel 58 MOVIPREP R 58 Lung Cancer Drug 58 topical anti infective 58 DiaKine 58 Juvaris BioTherapeutics 58 Phase 2b Trial 58 CRMD# 58 Zemiva TM 58 Vidaza azacitidine 58 gastro intestinal inflammation 58 predictive toxicology 58 Camvia 58 oral beclomethasone dipropionate 58 Neugene 58 Fraunhofer CMB 58 Announces Poster Presentations 58 Novel Vaccine 58 Gets FDA Clearance 58 ZOLINZA 57 Lixivaptan 57 Peer Reviewed Medical 57 humanized monoclonal 57 HCV polymerase 57 Fibrin Pad 57 ATL# [002] 57 Charlesson 57 NIH CounterACT 57 Prolongs Survival 57 Commercialize Novel 57 Anidulafungin 57 HDL Mimetic Peptide 57 histamine dihydrochloride 57 FDA Orphan Drug 57 systemic RNAi 57 Completes Dosing 57 Cancer Vaccines 57 Oral Mucositis 57 intranasal delivery 57 thetreatment 57 StaphVAX R 57 personalized cellular immunotherapy 57 mda 7 57 ospemifene 57 Tyrosine Kinase Inhibitor 57 Tobira Therapeutics 57 Bellicum 57 cancer immunotherapies 57 tiapamil 57 immune modulating 57 Valortim ® 57 RECOTHROM R 57 MelaFind R 57 Cytomegalovirus CMV 57 Ridaforolimus 57 BAL# [002] 57 systemic immunosuppressive drugs 57 PDE# inhibitors 57 Ramoplanin 57 Friedreich Ataxia FRDA 57 YONDELIS 57 tubulin inhibitor 57 Monoclonal Antibodies 57 Harry Palmin President 57 Onconase 57 Therapeutic Antibodies 57 Recombinant Human 57 L BLP# 57 liposome formulations 57 Companion Diagnostic 57 Sylvie Gregoire President 57 Adnectin 57 successfully commercialize Iluvien 57 Prestara TM 57 JAK inhibitors 57 Saegis Pharmaceuticals 57 antibody MAb 57 rPA 57 Nektar pulmonary 57 Ception Therapeutics 57 adenovector 57 Lupus Drug 57 faropenem 57 eligen 57 Rheumatoid Arthritis Drug 57 Synerx Pharma 57 preclinical efficacy 57 Ceragenix 57 Nektar proprietary 57 Hematide ™ 57 Spiegelmer ® 57 anticancer therapeutics 57 HQK 57 biotherapeutic drugs 57 Tß4 57 IMiDs R 57 Orencia abatacept 57 Avian Influenza Vaccine 57 rPA anthrax vaccine 57 Inflammatory Disease 57 CMV vaccine 57 FDA Clears 57 Rilonacept 57 PRT# 57 Capsulution 57 DermTech International 57 Caris MPI 57 OMNARIS HFA 57 Phase III Clinical Trial 57 Cardiotoxicity 57 NV1FGF 57 ALN HTT 57 Diabetic Foot Ulcer 57 Cx# [002] 57 Protectan 57 Hematological Malignancies 56 Syntonix 56 Microplasmin 56 Homspera TM 56 NurOwn 56 Cancidas 56 Preclinical Studies 56 Bayhill Therapeutics 56 please visit www.metabolon.com 56 immuno therapeutic 56 Vaccine Adjuvant 56 IV acetaminophen 56 synthetic retinoid 56 Shows Promise Against 56 Gamunex C 56 Milestone Payment From 56 oral PTH 56 HCV protease inhibitors 56 IMiDs ® 56 Poly ICLC 56 Phase 2a Trial 56 WRAIR 56 OTCBB PWRM.OB 56 Glaucoma Treatment 56 URG# 56 preclinical toxicology 56 HuMax TAC 56 Selective Electrochemical Tumor Ablation 56 Stapled Peptide 56 LibiGel ® 56 monoclonal antibody MAb 56 Evoltra ® 56 Pharmacogenomic 56 Aryplase 56 aerosolized KL4 surfactant 56 Expands Scientific Advisory 56 metastatic neuroendocrine tumors 56 Dr. Sosne 56 Bucindolol 56 EP #R 56 P#X# antagonist 56 MKC# MKC# PP 56 NS5A 56 anthrax monoclonal antibody 56 velafermin belinostat 56 thiazolides 56 UltiMAb ® 56 DAIDS 56 Panzem ® 56 pralatrexate injection folate analogue 56 MAGE A3 ASCI 56 rPA vaccine candidate 56 Degarelix 56 Metabolic Disorder 56 NeuroHealing 56 AzaSite Plus 56 Technosphere ® 56 photodisinfection 56 targeting PCSK9 56 miRagen Therapeutics 56 Aquoral TM 56 Develops Novel 56 PhG alpha 1 56 Exclusive License 56 Demonstrates Significant 56 Demonstrates Potential 56 RNAi therapeutic platform 56 Zybrestat 56 Akebia Therapeutics 56 Octreotide 56 THR beta agonist 56 ImQuest 56 treat chronic sinusitis 56 Adenovirus 56 Occlusin TM 56 GeoVax vaccine 56 MEK inhibitors 56 Panzem 56 Develop Novel 56 PHEMCE 56 #D#C# 56 glucokinase activator 56 Ascend Therapeutics 56 Receptos 56 Protein Therapeutics 56 Plasmin 56 Adult Stem Cell Therapy 56 neuronal nicotinic receptor NNR 56 Proellex TM 56 LUCASSIN 56 Panzem R NCD 56 Ichor Medical Systems 56 Tomophase 56 Vivecon 56 Hybridon 56 MAXY VII 56 EECP ® therapy 56 Malaria Vaccine 56 Submits NDA 56 Prosaptide 56 Trellis Bioscience 56 favorable pharmacokinetic profile 56 Cathepsin S 56 Anti Angiogenic 56 Silodosin 56 Aurexis 56 Inimex 56 EHT AGN 56 NAVISTAR R 56 ARRY # 56 Bioral ® 56 Hedgehog agonist 56 radezolid 56 neurology immunology 56 Revimmune TM 56 NEUGENE R 56 ABthrax TM 56 vivo glucose 56 CytomX Therapeutics 56 Vaxfectin 56 VNS Therapy TM 56 clevidipine 56 TransVax ™ 56 Influenza Vaccine 56 Embolic Protection Device 56 Anthim 56 HuMax EGFr 56 Prostate Cancer Vaccine 56 Prestara 56 MGN# 56 Novasome R 56 DCVax R 56 antibacterial therapeutics 56 FDA CDER 56 RNA antagonists 56 MorphoSys proprietary 56 AMEX KAL 56 Stromedix 56 Entereg R 56 VitiGam TM 56 product platforms AZX# 56 investigational therapies 56 Genvec 56 biocompatible coatings 56 PresbyLens ® 56 Aganocide 56 RNA Interference 56 zolpidem tartrate sublingual tablet 55 rhIGF-I/rhIGFBP-3 55 Voraxaze 55 Ca DTPA 55 Drug Repositioning 55 ketolide antibiotic 55 SomatoKine 55 Alferon LDO 55 SinuNase ™ 55 systemic fungal infections 55 Anticancer Drug 55 ActivX 55 Immunomedics Announces 55 Fodosine 55 biostatistical analysis 55 Juvaris 55 Humanetics 55 developing TB4 55 antibiofilm 55 pain palliation 55 Anticancer Agents 55 TLK# 55 pharmacological chaperone 55 Altastaph 55 Celator 55 DUROS 55 Zalypsis 55 ritonavir boosted danoprevir 55 Ebola SNALP 55 Micromet BiTE 55 Fragment Based 55 Orphan Drug status 55 SPL# Gel vaginal microbicide 55 Nanobody 55 AssureRx 55 mGlu2 3 55 CINQUIL 55 Preotact R 55 injectable formulations 55 monoclonal antibody mAb 55 BRAF inhibitor 55 Bellicum Pharmaceuticals Inc. 55 recombinant Factor VIII 55 SNS# T 55 Surfactant Replacement Therapy 55 Valortim 55 Microwave Ablation System 55 Ebola Vaccine 55 endothelin antagonist 55 Exelixis XL# 55 oral salmon calcitonin 55 Cyclosert TM 55 Development Authority BARDA 55 Tumor Targeting 55 INS# [001] 55 telomerase inhibitor 55 ALTROPANE R 55 DMD DMSc 55 AFRS TM 55 Initiates Clinical Trials 55 epigenetic therapies 55 Plexxikon proprietary 55 Vaxfectin TM 55 Dyloject TM 55 Cerashield ™ 55 chimeric monoclonal antibody 55 IND Application 55 Cardiometabolic 55 etanercept Enbrel 55 AE# vaccine 55 Earns Milestone Payment 55 SparVax TM 55 CCX# 55 ProNAi 55 Collaborators Publish 55 Anti Infective 55 Bioral 55 GLP toxicology studies 55 Universal Flu Vaccine 55 TB Vaccine 55 vitro ADME 55 antiinfective 55 eTag assays 55 Aptamer 55 PharmaNova 55 drug GAP #B# 55 Taligen Therapeutics 55 Therion Biologics 55 Antisense Drug 55 Schizophrenia Treatment 55 immunosuppressant therapies 55 TRIST study 55 anti infective therapies 55 CompuFlo 55 Durata 55 HTS assay 55 ConjuGon 55 mocetinostat MGCD# 55 Biotherapeutic 55 THALOMID 55 AERx R 55 Microneedle 55 Myoblast 55 Poly ICR 55 REGiMMUNE 55 Begins Shipment 55 Autoimmune Diseases 55 nalbuphine ER 55 histone deacetylase HDAC 55 Quark Pharmaceuticals 55 EGEN 55 ORENCIA R 55 RIGScan CR 55 proprietary radiolabeled monoclonal 55 Cellular Immunology 55 pharmacokinetic PK study 55 Zysolin TM 55 unoprostone isopropyl 55 cardio renal 55 DepoVax TM 55 QUADRAMET R 55 Tarceva TM 55 Alnylam RNAi 55 BEXXAR 55 Saforis 55 inhaled AAT 55 Submits Biologics License Application 55 Clinical Trials Consortium 55 MacuSight 55 ParagonDx 55 Maxy G# 55 Anti CD# Antibody 55 Novel Therapeutics 55 Announce Collaboration Agreement 55 SNT MC# 55 Bexion 55 antisense inhibitor 55 SansRosa 55 GATTEX TM 55 Seasonal Influenza Vaccine 55 humanized monoclonal antibodies 55 NP2 Enkephalin 55 Autoimmune Disease 55 RxKinetix 55 Chemophase 55 Sanvar 55 Contract Modification 55 therapeutic monoclonal antibodies 55 Fibrocell Science 55 adrenergic regulation 55 Inc Therapeutic Competitors 55 Neo Bladder Augment 55 Akesis Pharmaceuticals 55 Surfaxin LS 55 Thelin TM 55 Dry Powder Inhaler 55 optimal dosing regimens 55 Anti Angiogenesis 55 R#/MEM 55 Fast Track Designation 55 Novel Antibiotic 55 TOCOSOL 55 faropenem medoxomil 55 Clolar ® 55 Antibody Discovery 55 topical anti infectives 55 Integrated Preclinical 55 protein misfolding diseases 55 prophylactic vaccines 55 Cutanea 55 VisEn Medical 55 Soliris eculizumab 55 purinergic receptors P#X# 55 Resten NG 55 InterfeRx 55 Inovio Pharmaceuticals 55 leading oral taxane 55 MAXY G# 55 Mpex 55 Elestrin TM 55 Genentech Rituxan 55 molecular diagnostic assay 55 hematologic oncology 55 Azedra 55 A3 adenosine receptor 55 MediVas 55 tezampanel NGX# 55 ERYtech 55 TRANSDUR Bupivacaine 55 NEUGENE 54 Innate Immune 54 miglustat 54 BEMA Granisetron 54 IMPACS R 54 SoluBest 54 defensin mimetic antibiotic 54 GED aPC 54 acid phosphatase PAP 54 TransPharma 54 Asthma COPD 54 Peptimmune 54 Therapeutic Competitors companiesandmarkets.com adEgemonye 54 JAK3 54 BIIR 54 Avian Flu Vaccine 54 orally inhaled migraine 54 Interferon Alfa 54 Combidex 54 PGL# 54 Onalta ™ 54 POSIDUR TM 54 Catena ® 54 Solazed TM 54 Intravail R 54 OROS R Hydromorphone 54 omega interferon 54 immunotoxins 54 celgosivir 54 Cancer Vaccine 54 Molecular Diagnostic Test 54 PANVAC VF 54 Virosome Biologicals 54 Anavex #-# 54 Ibis T# 54 Prism Pharmaceuticals 54 Drug Eluting Stent System 54 Pivotal Trial 54 Amorcyte 54 patented Bioral 54 Samjin 54 MOZOBIL 54 Japanese Encephalitis Vaccine 54 MyVax 54 drug ISA# 54 AVI BioPharma Announces 54 Zavesca R 54 SIX RO ROG 54 Epiphany Biosciences 54 Cardio3KG 54 REG1 54 TARIS 54 novel RNAi therapeutics 54 Daniel Von Hoff 54 Referenced EEG 54 Mutation Analysis 54 inherited retinal 54 Protein Expression 54 Activity Assay 54 Biostatistical 54 Conatus Pharmaceuticals 54 Multiple Ascending Dose 54 Extina 54 DiLA2 54 SUTENT ® 54 molecular imaging radiopharmaceuticals 54 biologic therapeutics 54 Expanded Indication 54 novel emulsion formulation 54 GTC recombinant human 54 antibacterial antiviral 54 orally inhaled 54 biosurgical 54 diagnostics therapeutics 54 anti CD# antibodies 54 NNR Therapeutics 54 DEEP AF 54 Pyridorin 54 TELINTRA 54 invasive candidiasis 54 CNS Therapeutics 54 therapeutic peptide 54 GVAX cancer 54 TheraSphere R 54 LUVENIQ 54 Regado 54 NovaBay Pharmaceuticals 54 Eric von Hofe 54 OMP designation 54 Annexin A5 54 TriGrid 54 immunotherapeutics 54 IDRI 54 phosphatidylserine PS targeting 54 Phylonix 54 please visit http:/www.sunesis.com 54 Exploit collaboration 54 Amgen denosumab 54 broad spectrum cephalosporin 54 AmpliChip 54 Co Receptor Tropism 54 WavSTAT 54 RPTP 54 NanoCrystal 54 NIH SBIR 54 VBLOC TM 54 MabThera rituximab 54 Biological Detection 54 plasma kallikrein inhibitor 54 MyVax ® 54 SCIB1 54 ENTEREG ® 54 synthetic peptide containing 54 Nasdaq HALO 54 Accelovance 54 ganaxolone 54 monoclonal antibody therapeutics 54 Oligonucleotide 54 next generation URAT1 54 Proteasome 54 RELOVAIR ™ 54 Aerosurf 54 albiglutide 54 fluoroquinolone antibiotic 54 Dupuytren Contracture 54 Human Antibody 54 TÎ ² 4 54 Hemopurifier ® 54 cytotoxics 54 Isavuconazole 54 PSMA ADC 54 ERYtech Pharma 54 proprietary capillary aerosolization 54 BCLI 54 Electronic Brachytherapy System 54 SBIR Phase II 54 BT VACC TM 54 GTC recombinant form 54 Sirnaomics 54 Topical Treatment 54 TYGACIL 54 antibiotic resistant bacterial infections 54 Congressionally Directed Medical 54 neuraminidase inhibitor 54 ArQule Kinase Inhibitor Platform 54 recombinant interferon 54 plasmid DNA pDNA 54 Cenomed 54 Vaxfectin TM adjuvant 54 LEAD Therapeutics 54 TYZEKA 54 Manja Bouman CEO 54 Neural Stem Cell 54 AtherOx 54 CONBRIZA 54 platform HDL Mimetic 54 ATryn ® 54 MVA BN R 54 OraTest 54 Patent Issued 54 Vysis 54 DepoCyt 54 preclinical pharmacology 54 DuraSite ® 54 HuMax 54 protein kinase inhibitors 54 anticoagulant reversing agent 54 Litx 54 Preclinical Development 54 Perforomist ™ Inhalation Solution 54 Aerovance 54 stent coating 54 Milestone Payment 54 PF # [002] 54 Developmental Therapeutics Program 54 Ercole Biotech 54 Warfarin Coumadin 54 TASKi3 54 Antigenics QS 54 Tissue Repair 54 Rotary VAD 54 siRNA therapeutics 54 Selenia Dimensions System 54 beta lactamase inhibitor 54 mifamurtide L MTP PE 54 Chemokine Therapeutics 54 Galenea 54 Alnara Pharmaceuticals 54 CAMPATH 54 OMAPRO 54 echinocandins 54 Dendrimer 54 Gastrotech 54 HCV nucleoside polymerase inhibitors 54 Protein Interactions 54 neratinib 54 Transdermal Delivery 54 Freedom Meditech 53 VIVITROL ® 53 Neurome 53 GenPath 53 Icatibant 53 Immune Mediated 53 Ocular Disease 53 Elusys 53 Ketotransdel 53 UC CEIN 53 PLx 53 GRNVAC1 53 Viral Immunotherapy platform 53 non porcine pancreatic 53 Microbial Genomics 53 Vegenics 53 Rasagiline 53 Recombinant Protein 53 Capesaris 53 Nanobody ® 53 CIP TRAMADOL ER 53 tropism testing 53 Orphan Drug Status 53 acute peripheral arterial 53 antiviral therapeutics 53 Nanoemulsion 53 torezolid phosphate 53 cyclophilin inhibitors 53 efalizumab 53 Virulizin ® 53 Captisol ® 53 direct thrombin inhibitors 53 Uracyst R Test 53 Islet Transplantation 53 Avila Therapeutics 53 Mepact 53 Zosano Pharma 53 investigational hepatitis B 53 Theranostics 53 nucleoside tide 53 FDA Approvable Letter 53 biomarker identification 53 AERx iDMS 53 RNA Interference RNAi 53 topical antifungal 53 HuCAL antibodies 53 including eniluracil ADH 53 Cellular Tissue 53 LymphoStat B TM 53 ORWH 53 multicenter clinical trials 53 Therapeutic antibodies 53 Antigen Specific 53 alemtuzumab MS 53 ImmuKnow R 53 Mesafem 53 Chemoprevention 53 oxypurinol 53 Quark Biotech 53 Zenvia ™ 53 dacetuzumab 53 TetraLogic 53 NABTT 53 personalized immunotherapy 53 RECOTHROM ® 53 Augment ™ 53 Insegia 53 pegylated alpha interferon 53 Quark Biotech Inc. 53 ularitide 53 Arno Therapeutics 53 Pervasis 53 Regado Biosciences 53 siRNA Delivery 53 Vaccine Adjuvants 53 antigen rPA anthrax 53 Intravail ® 53 GelSite polymer 53 Hervé Hoppenot President 53 ENLIGHT 53 immunosuppression specifically 53 SynCon 53 Aegera 53 Transdermal Drug 53 HHSN#C 53 ZEVALIN ® 53 biologic therapies 53 StaphVAX 53 Scientific Advisory Boards 53 DepoDur 53 Glycosylation 53 Sanvar R 53 OTCBB PYTO 53 Clinical Outcome 53 Genzyme Myozyme 53 GAMMAGARD 53 BLA filing 53 Oasmia 53 EnVivo Pharmaceuticals 53 recombinant protein therapeutics 53 Cethrin R 53 Progenitor Cell 53 Cerashield TM 53 ARIKACE ™ 53 Metastatix 53 NeoLipid TM 53 SMIP 53 predictive biomarkers 53 antigen sparing 53 biodefense pathogens 53 peptide conjugated 53 Protein Structure Initiative 53 Rhucin ® recombinant 53 GENASIS 53 SynCon ™ DNA 53 BiTE Antibody 53 NovaBay Aganocide compounds 53 Agios Pharmaceuticals 53 Zosano 53 Ore Pharmaceuticals 53 liposomal ciprofloxacin 53 Velcura 53 LGLS 53 synDNA 53 novel immunotherapeutic 53 Government Qualifying Therapeutic 53 Preclinical Testing 53 Alvesco R 53 selective immunoproteasome inhibitor 53 ZaBeCor 53 RX ACCULINK 53 SURFAXIN 53 Accium 53 Ataluren 53 IV Busulfex 53 candidate NGX 53 solid organ transplantation 53 Cintredekin besudotox 53 Vascular Wrap TM 53 Ophthotech 53 Etravirine 53 Inflammatory diseases 53 hoFH 53 Hedgehog antagonist 53 SynCon TM 53 LEP ETU 53 Announces FDA Clearance 53 Trastuzumab DM1 53 investigational smallpox vaccine 53 Pandemic Flu Vaccine 53 Patent Broadly Covering 53 gastrointestinal motility disorders